Table 2.
Rest | 20 W | Symptom‐Limited Maximal Exercise | ANOVA Results, P Value | ||||||
---|---|---|---|---|---|---|---|---|---|
Control | HFpEF | Control | HFpEF | Control | HFpEF | HF | Stage | HF*Stage | |
Pulmonary gas exchange | |||||||||
VO2, mL/min | 304±26 | 316±21 | 786±42 | 640±43* | 1264±121 | 877±60* | 0.008 | <0.001 | 0.005 |
VO2, mL/min per kg | 3.5±0.2 | 3.2±0.2 | 9.1±0.5 | 6.5±0.4* | 14.5±1.1 | 9.0±0.7* | <0.001 | <0.001 | 0.001 |
VCO2, mL/min | 240±17 | 260±±19 | 649±51 | 525±38 | 1299±141 | 809±60* | 0.002 | <0.001 | <0.001 |
RER | 0.80±0.02 | 0.82±0.03 | 0.82±0.04 | 0.82±0.01 | 1.02±0.03 | 0.92±0.02* | 0.161 | <0.001 | 0.035 |
RPE | 7.3±0.7 | 6.0±0.5 | 10.8±0.8 | 11.7±0.9 | 17.1±0.9 | 14.6±0.8 | 0.255 | <0.001 | 0.060 |
Dyspnea | 1.1±0.5 | 1.1±0.5 | 2.9±0.8 | 4.4±0.6 | 7.6±1.0 | 7.0±0.5 | 0.940 | <0.001 | 0.195 |
VE, L/min | 9.4±0.8 | 9.4±0.7 | 23.5±3.7 | 18.5±1.3 | 45.2±5.8 | 28.2±2.4* | 0.007 | <0.001 | 0.012 |
fb, breaths per min | 15.7±1.5 | 18.8±1.2 | 27.9±4.5 | 26.7±1.4 | 35.7±4.9 | 34.1±2.2 | 0.979 | <0.001 | 0.378 |
VT, mL | 657±77 | 529±36 | 892±59 | 716±48* | 1360±170 | 844±54* | 0.003 | <0.001 | 0.009 |
PETCO2, mm Hg | 33.1±1.7 | 37.4±1.1* | 35.2±1.6 | 35.8±1.3 | 33.7±1.9 | 34.9±1.3 | 0.298 | 0.061 | 0.066 |
PECO2/PETCO2 | 0.69±0.02 | 0.66±0.01 | 0.75±0.01 | 0.73±0.01 | 0.79±0.01 | 0.76±0.01* | 0.105 | <0.001 | 0.960 |
VE/VCO2 | 39.7±2.3 | 36.8±1.4 | 34.9±2.3 | 36.0±1.6 | 34.7±2.4 | 35.3±1.6 | 0.863 | 0.073 | 0.290 |
VD/VT | 0.35±0.03 | 0.40±0.02 | 0.28±0.02 | 0.35±0.02* | 0.24±0.02 | 0.30±0.02 | 0.025 | <0.001 | 0.889 |
AaDO2, mm Hg | 18.4±3.4 | 22.1±1.8 | 19.0±3.3 | 28.7±4.1 | 22.2±1.6 | 28.8±2.3 | 0.187 | 0.321 | 0.633 |
Hemodynamics | |||||||||
Cardiac output, L/min | 6.5±0.6 | 7.4±0.6 | 9.3±0.4 | 7.5±0.6* | 11.8±0.8 | 9.1±0.7* | 0.154 | <0.001 | 0.004 |
Cardiac index, L/min per m2 | 3.2±0.2 | 3.4±0.2 | 4.6±0.2 | 3.5±0.3* | 5.8±0.2 | 4.2±0.3* | 0.026 | <0.001 | 0.001 |
HR, beats per min | 70±5 | 72±3 | 91±7 | 89±4 | 121±11 | 98±5* | 0.307 | <0.001 | 0.010 |
% predicted maximal HR | 42±8 | 47±9 | 55±12 | 58±12 | 73±20 | 63±13 | 0.847 | <0.001 | 0.003 |
SV, mL | 97±11 | 103±8 | 108±10 | 85±6* | 106±12 | 96±8 | 0.449 | 0.586 | 0.021 |
MAP, mm Hg | 97±5 | 99±3 | 113±5 | 115±5 | 122±5 | 116±5 | 0.958 | <0.001 | 0.166 |
RAPm, mm Hg | 7±1 | 12±1* | 10±1 | 21±2* | 11±1 | 21±1* | <0.001 | <0.001 | 0.003 |
PAPm, mm Hg | 18±1 | 29±2* | 26±1 | 43±3* | 29±1 | 43±3* | <0.001 | <0.001 | 0.007 |
PCWPm, mm Hg | 10±1 | 18±1* | 16±1 | 30±2* | 18±2 | 30±2* | <0.001 | <0.001 | 0.014 |
TPG, mm Hg | 9.1±1.6 | 11.0±1.6 | 10.1±1.3 | 12.9±2.4 | 10.7±1.8 | 12.4±2.2 | 0.474 | 0.296 | 0.809 |
PVR, mm Hg/L per min | 1.5±0.3 | 1.9±0.4 | 1.1±0.2 | 2.4±0.9 | 1.0±0.2 | 1.6±0.4 | 0.269 | 0.200 | 0.308 |
PA compliance, mL/mm Hg | 7.7±1.3 | 5.2±0.7 | 5.7±0.6 | 2.8±0.3* | 5.2±0.8 | 3.3±0.4* | 0.002 | 0.002 | 0.243 |
Lung diffusing capacity | |||||||||
DLCO, mL/min per mm Hg | 16.4±2.3 | 10.4±0.7* | 20.3±2.8 | 13.0±0.9* | 23.8±3.6 | 14.6±1.1* | 0.003 | <0.001 | 0.113 |
DLNO, mL/min per mm Hg | 48.0±6.5 | 29.3±2.4* | 62.1±8.5 | 37.4±2.2* | 73.4±10.9 | 42.8±2.7* | 0.001 | <0.001 | 0.081 |
Dm, mL/min per mm Hg | 28.4±3.9 | 16.8±1.6* | 37.9±5.4 | 21.7±1.2* | 45.5±7.4 | 25.0±1.5* | <0.001 | <0.001 | 0.073 |
Vc, mL | 84.9±11.2 | 69.5±6.0 | 85.3±9.2 | 75.6±7.2 | 100.9±12.6 | 83.0±8.8 | 0.263 | 0.129 | 0.918 |
Blood gases | |||||||||
SaO2 | 97±0.81 | 95±0.50 | 96±0.88 | 94±0.61 | 98±0.56 | 95±1.02 | 0.027 | 0.196 | 0.572 |
PaCO2 | 36±2.14 | 42±1.13* | 37±2.26 | 41±1.33 | 35±2.28 | 39±1.74 | 0.471 | <0.001 | 0.003 |
PaO2 | 84±4.61 | 72±3.04* | 85±5.50 | 72±2.81* | 90±3.61 | 75±3.67* | 0.011 | 0.116 | 0.897 |
ANOVA results include the P value of between‐patient effect (heart failure [HF]), within‐patient effect (stage), and the interaction between the 2 effects (HF*stage). Data are presented as mean±SEM. AaDO2 indicates alveolar to arterial O2 difference; DLCO, lung diffusing capacity for carbon monoxide; DLNO, lung diffusing capacity for nitric oxide; Dm, alveolar‐capillary membrane conductance; fb, breathing frequency; HFpEF, heart failure with preserved ejection fraction; HR, heart rate; MAP, mean arterial pressure; PA, pulmonary artery, PAPm, mean pulmonary artery pressure; PCWPm, mean pulmonary capillary wedge pressure; PECO2, expired partial pressure of carbon dioxide; PETCO2, end‐tidal partial pressure of carbon dioxide; PVR, pulmonary vascular resistance; RAPm, mean right atrial pressure; RER, respiratory exchange ratio; RPE, rate of perceived exertion; SaO2, arterial O2 saturation; SV, stroke volume; TPG, transpulmonary gradient; Vc, pulmonary capillary blood volume; VCO2, carbon dioxide production; VD/VT, ratio of dead space to tidal volume; VE, minute ventilation; VO2, O2 consumption; and VT, tidal volume.
Indicates post hoc difference between groups.